PolyPeptide Group AG (PPGN) — Capital Reinvestment Ratio
Latest as of June 2025:
0.98x
PolyPeptide Group AG (PPGN) has a Capital Reinvestment Ratio of 0.98x as of June 2025, meaning it reinvests 1% of its operating cash flow (CHF49.66 Million) in capital expenditures (CHF48.68 Million). See PolyPeptide Group AG free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.98x
Capex / Operating Cash Flow
Operating Cash Flow
CHF49.66 Million
CHF
Capital Expenditures
CHF48.68 Million
CHF
Data as of
Jun 2025
Most recent filing
PolyPeptide Group AG Capital Reinvestment Ratio (2018–2024)
This chart tracks PolyPeptide Group AG's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for PolyPeptide Group AG (2018–2024)
Year-by-year Capital Reinvestment Ratio for PolyPeptide Group AG from 2018 to 2024. For live market cap and broader valuation context, see how much is PolyPeptide Group AG worth.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.97x | CHF89.40 Million | CHF86.97 Million | ▼ -37.4% |
| 2023 | 1.55x | CHF36.48 Million | CHF56.73 Million | ▼ -89.2% |
| 2022 | 14.43x | CHF5.46 Million | CHF78.76 Million | ▲ +964.7% |
| 2021 | 1.35x | CHF57.35 Million | CHF77.71 Million | ▲ +65.0% |
| 2020 | 0.82x | CHF49.48 Million | CHF40.62 Million | ▲ +131.6% |
| 2019 | 0.35x | CHF55.60 Million | CHF19.70 Million | ▼ -55.6% |
| 2018 | 0.80x | CHF22.94 Million | CHF18.30 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow